NSV MANAGEMENT LLC

Thesis

NSV Management LLC, operating through entities like NSV Wolf Capital and New Science Ventures, is a hybrid venture capital firm founded in 2002. Their strategy combines early-stage fund-of-funds investing with direct startup investments, aiming to provide balanced access to venture capital while retaining upside potential. They back experienced early-stage VC fund managers and leverage this intelligence for direct investments and to assist their Limited Partners. NSV focuses on transformative technologies in Health/Life Sciences (therapeutics, platforms, diagnostics, devices, health IT, consumer products), Information Technology, Energy (clean, abundant, secure systems), Mobility (efficient, sustainable transport), and Industry (domestic production/supply). They primarily invest at the pre-seed and seed stages, and in hardware/software innovations up to Series B, sometimes co-creating companies. Their geographic focus is primarily the United States, with ties to North American research hubs, but they also invest in global founders. NSV employs a flexible strategy, leading, following, or being the sole investor, and acts as a patient, supportive investor. NSV Wolf Capital closed Fund IV in 2022. NSV Investments I, L.P. has a portfolio value of $13,021,020 and a notable holding in Ventyx Biosciences, Inc. The firm encourages direct contact for pitches. NSV Management LLC is headquartered in Greenwich, CT.

Related lists

• Pre-seed Climate investors
• Pre-seed Healthcare investors
• Seed-stage Climate investors